{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T08:12:52Z","timestamp":1772784772844,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010730","name":"Temasek Life Sciences Laboratory","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010730","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.vaccine.2019.11.080","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T21:40:58Z","timestamp":1578433258000},"page":"1286-1290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Modification of neutralizing epitopes of hemagglutinin for the development of broadly protective H9N2 vaccine"],"prefix":"10.1016","volume":"38","author":[{"given":"Zhong Wee","family":"Poh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenzhang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subaschandrabose Rajesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui Yee","family":"Yong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9816-5908","authenticated-orcid":false,"given":"Mookkan","family":"Prabakaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2019.11.080_b0005","doi-asserted-by":"crossref","first-page":"26","DOI":"10.7774\/cevr.2013.2.1.26","article-title":"H9N2 avian influenza virus in Korea: evolution and vaccination","volume":"2","author":"Lee","year":"2013","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.vaccine.2019.11.080_b0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13567-016-0322-4","article-title":"Deterioration of eggshell quality in laying hens experimentally infected with H9N2 avian influenza virus","volume":"47","author":"Qi","year":"2016","journal-title":"Vet Res"},{"issue":"1","key":"10.1016\/j.vaccine.2019.11.080_b0015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s13238-014-0111-7","article-title":"H9N2 influenza virus in China: a cause of concern","volume":"6","author":"Sun","year":"2015","journal-title":"Protein Cell"},{"issue":"Pt 7","key":"10.1016\/j.vaccine.2019.11.080_b0020","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1099\/vir.0.82783-0","article-title":"Antigenic and genetic characterization of H9N2 swine influenza viruses in China","volume":"88","author":"Cong","year":"2007","journal-title":"J Gen Virol"},{"issue":"20","key":"10.1016\/j.vaccine.2019.11.080_b0025","doi-asserted-by":"crossref","first-page":"9679","DOI":"10.1128\/JVI.75.20.9679-9686.2001","article-title":"Cocirculation of avian H9N2 and contemporary \u201chuman\u201d H3N2 influenza A viruses in pigs in southeastern China: potential for genetic reassortment?","volume":"75","author":"Peiris","year":"2001","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2019.11.080_b0030","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/jmv.24231","article-title":"Human infection with an avian influenza A (H9N2) virus in the middle region of China","volume":"87","author":"Huang","year":"2015","journal-title":"J Med Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2019.11.080_b0035","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jinf.2017.01.003","article-title":"Human infection with an avian influenza A\/H9N2 virus in Guangdong in 2016","volume":"74","author":"Yuan","year":"2017","journal-title":"J Infect"},{"issue":"10","key":"10.1016\/j.vaccine.2019.11.080_b0040","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1073\/pnas.1019109108","article-title":"High genetic compatibility and increased pathogenicity of reassortants derived from avian H9N2 and pandemic H1N1\/2009 influenza viruses","volume":"108","author":"Sun","year":"2011","journal-title":"Proc Natl Acad Sci"},{"issue":"Pt 12","key":"10.1016\/j.vaccine.2019.11.080_b0045","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1099\/vir.0.2008\/005652-0","article-title":"Characterization of H9N2 influenza viruses isolated from vaccinated flocks in an integrated broiler chicken operation in eastern China during a 5 year period (1998\u20132002)","volume":"89","author":"Zhang","year":"2008","journal-title":"J Gen Virol"},{"issue":"Pt 1","key":"10.1016\/j.vaccine.2019.11.080_b0050","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1099\/vir.0.024992-0","article-title":"Rapid evolution of low-pathogenic H9N2 avian influenza viruses following poultry vaccination programmes","volume":"92","author":"Park","year":"2011","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2019.11.080_b0055","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0042-6822(88)90103-1","article-title":"Protection of chickens from lethal influenza infection by vaccinia-expressed hemagglutinin","volume":"167","author":"Chambers","year":"1988","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.vaccine.2019.11.080_b0060","doi-asserted-by":"crossref","first-page":"e5672","DOI":"10.1371\/journal.pone.0005672","article-title":"Combination therapy using chimeric monoclonal antibodies protects mice from lethal H5N1 infection and prevents formation of escape mutants","volume":"4","author":"Prabakaran","year":"2009","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.vaccine.2019.11.080_b0065","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints12","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2019.11.080_b0070","doi-asserted-by":"crossref","DOI":"10.1002\/0471142956.cya03js37","article-title":"Production of monoclonal antibodies","author":"Yokoyama","year":"2006","journal-title":"Curr Protoc Cytom"},{"issue":"22","key":"10.1016\/j.vaccine.2019.11.080_b0075","doi-asserted-by":"crossref","first-page":"11822","DOI":"10.1128\/JVI.00891-10","article-title":"Neutralizing epitopes of influenza virus hemagglutinin: target for the development of a universal vaccine against H5N1 lineages","volume":"84","author":"Prabakaran","year":"2010","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2019.11.080_b0080","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/JVI.78.1.240-249.2004","article-title":"Structural differences among hemagglutinins of influenza A virus subtypes are reflected in their antigenic architecture: analysis of H9 escape mutants","volume":"78","author":"Kaverin","year":"2004","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2019.11.080_b0085","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1007\/s00705-008-0243-2","article-title":"Antigenic structure of the hemagglutinin of H9N2 influenza viruses","volume":"153","author":"Okamatsu","year":"2008","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2019.11.080_b0090","doi-asserted-by":"crossref","first-page":"18745","DOI":"10.1038\/srep18745","article-title":"Antigenic mapping of an H9N2 avian influenza virus reveals two discrete antigenic sites and a novel mechanism of immune escape","volume":"6","author":"Peacock","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2019.11.080_b0095","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.virol.2008.08.002","article-title":"Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant","volume":"380","author":"Prabakaran","year":"2008","journal-title":"Virology"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2019.11.080_b0100","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0264-410X(00)00259-0","article-title":"Effect of different baculovirus inactivation procedures on the integrity and immunogenicity of porcine parvovirus-like particles","volume":"19","author":"Rueda","year":"2000","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2019.11.080_b0105","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3201\/eid2501.180616","article-title":"Association of increased receptor-binding avidity of influenza A(H9N2) viruses with escape from antibody-based immunity and enhanced zoonotic potential","volume":"25","author":"Sealy","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"13","key":"10.1016\/j.vaccine.2019.11.080_b0110","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.vaccine.2019.02.012","article-title":"Enhanced cross-lineage protection induced by recombinant H9N2 avian influenza virus inactivated vaccine","volume":"37","author":"Wang","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.080_bib111","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0264-410X(91)90055-B","article-title":"Efficacy of nucleoprotein and hemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens","volume":"9","author":"Webster","year":"1991","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19316342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19316342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:37:58Z","timestamp":1759401478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19316342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0264410X19316342"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.11.080","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modification of neutralizing epitopes of hemagglutinin for the development of broadly protective H9N2 vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.11.080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}